166 related articles for article (PubMed ID: 29778463)
1. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
2. Investigation on potential associations of oxidatively generated DNA/RNA damage with lung, colorectal, breast, prostate and total cancer incidence.
Gào X; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Brenner H; Schöttker B
Sci Rep; 2019 May; 9(1):7109. PubMed ID: 31068619
[TBL] [Abstract][Full Text] [Related]
3. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
[TBL] [Abstract][Full Text] [Related]
4. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
5. Oxidatively Damaged DNA/RNA and 8-Isoprostane Levels Are Associated With the Development of Type 2 Diabetes at Older Age: Results From a Large Cohort Study.
Schöttker B; Xuan Y; Gào X; Anusruti A; Brenner H
Diabetes Care; 2020 Jan; 43(1):130-136. PubMed ID: 31653645
[TBL] [Abstract][Full Text] [Related]
6. The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study.
Gào X; Zhang Y; Burwinkel B; Xuan Y; Holleczek B; Brenner H; Schöttker B
Clin Epigenetics; 2019 Jan; 11(1):14. PubMed ID: 30678711
[TBL] [Abstract][Full Text] [Related]
7. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
8. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
9. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
10. Nitric Oxide Metabolites and Lung Cancer Incidence: A Matched Case-Control Study Nested in the ESTHER Cohort.
Gào X; Xuan Y; Benner A; Anusruti A; Brenner H; Schöttker B
Oxid Med Cell Longev; 2019; 2019():6470950. PubMed ID: 31565153
[TBL] [Abstract][Full Text] [Related]
11. Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
Cohn E; Lurie I; Yang YX; Bilker WB; Haynes K; Mamtani R; Shacham-Shmueli E; Margalit O; Boursi B
J Trauma Stress; 2018 Dec; 31(6):919-926. PubMed ID: 30520529
[TBL] [Abstract][Full Text] [Related]
12. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women.
Heikkilä K; Nyberg ST; Theorell T; Fransson EI; Alfredsson L; Bjorner JB; Bonenfant S; Borritz M; Bouillon K; Burr H; Dragano N; Geuskens GA; Goldberg M; Hamer M; Hooftman WE; Houtman IL; Joensuu M; Knutsson A; Koskenvuo M; Koskinen A; Kouvonen A; Madsen IE; Magnusson Hanson LL; Marmot MG; Nielsen ML; Nordin M; Oksanen T; Pentti J; Salo P; Rugulies R; Steptoe A; Suominen S; Vahtera J; Virtanen M; Väänänen A; Westerholm P; Westerlund H; Zins M; Ferrie JE; Singh-Manoux A; Batty GD; Kivimäki M;
BMJ; 2013 Feb; 346():f165. PubMed ID: 23393080
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function and cancer risk: a prospective population study.
Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
[TBL] [Abstract][Full Text] [Related]
14. The Use of Telmisartan and the Incidence of Cancer.
Tascilar K; Azoulay L; Dell'Aniello S; Bartels DB; Suissa S
Am J Hypertens; 2016 Dec; 29(12):1358-1365. PubMed ID: 27557862
[TBL] [Abstract][Full Text] [Related]
15. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study.
Marrone MT; Mondul AM; Prizment AE; Couper D; Barber JR; Chappidi MR; Joshu CE; Platz EA
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34738072
[TBL] [Abstract][Full Text] [Related]
16. Survival patterns for the top four cancers in Canada: the effects of age, region and period.
Ugnat AM; Xie L; Semenciw R; Waters C; Mao Y
Eur J Cancer Prev; 2005 Apr; 14(2):91-100. PubMed ID: 15785312
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
18. Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort.
Luo J; Xu X
Carcinogenesis; 2020 Jun; 41(4):478-482. PubMed ID: 31872237
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
Ordóñez-Mena JM; Schöttker B; Mons U; Jenab M; Freisling H; Bueno-de-Mesquita B; O'Doherty MG; Scott A; Kee F; Stricker BH; Hofman A; de Keyser CE; Ruiter R; Söderberg S; Jousilahti P; Kuulasmaa K; Freedman ND; Wilsgaard T; de Groot LC; Kampman E; Håkansson N; Orsini N; Wolk A; Nilsson LM; Tjønneland A; Pająk A; Malyutina S; Kubínová R; Tamosiunas A; Bobak M; Katsoulis M; Orfanos P; Boffetta P; Trichopoulou A; Brenner H;
BMC Med; 2016 Apr; 14():62. PubMed ID: 27044418
[TBL] [Abstract][Full Text] [Related]
20. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
